The Joint Corp. Stock Price and Value Analysis

Should you buy The Joint Corp. stock? (NasdaqCM:JYNT). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the JYNT Numbers

JYNT Price
(The Joint Corp. stock price per share)
$15.54
[?] PE Ratio versus Sector 14% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Unknown stocks
[?] Free Cash Flow Jitter 107%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,164,827 shares shorted. With 11,804,188 shares available for purchase and an average trading volume over the past 10 trading days of 116,970, it would take at least 9.958 days for all of the short holders to cover their shorts.

Is The Joint Corp. Stock on Sale?

Based on our analysis, we believe that you should not buy The Joint Corp. right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy JYNT Stock?

Does The Joint Corp. have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.